Centre for Biosimilars publishes America’s Health Insurance Plans

On 16 April 2020, the Centre for Biosimilars published America’s Health Insurance Plans call for further action to address barriers to competition for biosimilars. This action includes shortening product exclusivity periods, creating a searchable Purple Book, introducing more and better education about biosimilars and eliminating product hopping.